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SUMMARY
Human neutrophils and dibutyryl-cAMP (Bt2cAMP)-differentiated
HL-60 cells possess receptors for the chemotactic peptide
N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMet-Leu-Phe),
which mediate activation of phospholipase C, with subsequent
increase in cytosolic Ca2 concentration ([Ca2]) and activation
of specific cell functions. In many cell types, histamine, via H1
receptors, activates phospholipase C, but it is unknown whether
neutrophilic cells possess functional H1 receptors. We compared
the effects of histamine with those offMet-Leu-Phe on activation
of these cells. In Bt2cAMP-differentiated HL-60 cells, substances
increased [Ca21 in the effectiveness order fMet-Leu-Phe >
histamine > betahistine. Pertussis toxin diminished fMet-Leu-
Phe-induced rises in [Ca21 to a greater extent than those
induced by histamine. H1 but not H2 antagonists inhibited hista-
mine- and betahistine-induced rises in [Ca2]. fMet-Leu-Phe and
histamine activated phospholipase C and increased [Ca2]
through release of Ca2 from intracellular stores and sustained
influx of Ca2 from the extracellular space. The substances also
induced Mn2 influx. Ca2 and Mn2 influxes were inhibited by 1-
-[3-(4-methoxyphenyI)propoxyI]-4-methoxyphenethyl-1H-im-
idazole hydrochloride (SK&F 96365). The stimulatory effects of
histamine on [Ca2] were more sensitive to inhibition by 49-
phorbol 12-myristate 1 3-acetate than were those of fMet-Leu-
Phe. Unlike fMet-Leu-Phe, histamine did not activate superoxide
anion formation, release of fl-glucuronidase, and tyrosine phos-
phorylation. In neutrophils, histamine and betahistine did not
induce rises in [Ca21. Our data show that (i) in Bt2cAMP-
differentiated HL-60 cells, histamine increases [Ca2] via H1
receptors coupled to pertussis toxin-sensitive and possibly, per-
tussis toxin-insensitive heterotrimeric regulatory guanine nucleo-
tide-binding proteins, (ii) histamine activates nonselective cation
channels, and (iii) unlikefMet-Leu-Phe, histamine is an incomplete
secretagogue.
The intercellular signal molecule histamine mediates its ef-
fects through H1, H2, and H3 receptors (1, 2). Stimulation of
H1 receptors results in the activation of phospholipase C, which
catalyzes phosphoinositide degradation to diacylglycerol and
InsP3; diacylglycenol activates protein kinase C, and InsP3
mobilizes Ca2 from intracellular stones, resulting in an increase
in [Ca2]1 (1-3). H1 Receptors interact with pertussis toxin-
sensitive or pertussis toxin-insensitive G proteins, depending
on the cell type studied (3-7). H2 Receptors interact with the
G protein G8, leading to the activation of adenylyl cyclase, with
subsequent increase in cAMP (1-3).
Neutrophilic cells, i.e., neutnophils and differentiated HL-60
cells, possess receptors for the chemotactic peptide fMet-Leu-
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Phe, which couple to pertussis toxin-sensitive G proteins (8-
20). fMet-Leu-Phe induces activation ofphospholipase C, phos-
phorylation of tynosine, and opening of nonselective cation
channels, which mediate sustained influx of Ca2 from the
extracellular space (8-10, 20-22). Exposure of these cells to
fMet-Leu-Phe culminates in activation of NADPH oxidase-
catalyzed O2 formation and in release of (3-glucunonidase from
azunophilic granules (8-10, 13, 23, 24). Neutnophilic cells and
HL-60 pnomyelocytes possess H2 receptors; activation of these
receptors leads to inhibition of fMet-Leu-Phe-stimulated 02
formation and induction of cell differentiation, respectively
(25-31). It is, however, unknown whether human myeloid cells
possess functional H1 receptors, although the results of binding
studies suggested the presence of such receptors (32-34). By
analogy to fonmyl peptide receptors, activation of H1 receptors
in myeloid cells would be expected to result in increases in
ABBREVIATIONS: lnsP3, inositol trisphosphate; Bt2cAMP, dibutyryl-cAMP; [Ca21, cytosolic Ca2 concentration; EGTA, ethylene
bis(oxyethylenenitnlo)tetraacetic acid; G protein, heterotnmeric regulatory guanine nucleotide-binding protein; fMet-Leu-Phe, N-formyl-L-methionyl-L-
leucyl-L-phenylalanine; fura-2/AM, fura-2/acetoxymethyl ester; 02, superoxide anion; PDD, 4a-phorbol-i2,i 3-didecanoate; PMA, 4f-phorbol 12-
mynstate i 3-acetate; SK&F 96365, i -fl-[3-(4-methoxyphenyl)propoxyl]-4-methoxyphenethyI-iH-imidazole hydrochloride; HEPES, 4-(2-hydroxyle-
thyl)-i -piperazineethanesulfonic acid.
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[Ca2] and stimulation of 02 formation. We and others could
not obtain evidence to support the assumption that H1 receptors
play a part in the activation of 02 formation in human neu-
trophils (27, 29).
HL-60 cells differentiated towards neutrophils with
Bt2cAMP are a widely used model system to study signal
transduction processes in human myeloid cells (11-16, 18).
Among other receptors, these cells very effectively express
functional ATP and UTP receptors (12-15). These receptors
couple to both pertussis toxin-sensitive and pertussis toxin-
insensitive G proteins, leading to activation of phospholipase
C (12-15, 18). In Bt2cAMP-differentiated HL-60 cells, ATP
and UTP per se stimulate 02 formation and (3-glucuronidase
release, whereas in human neutrophils they do not (12, 13, 24).
All these findings prompted us to address the question of
whether Bt2cAMP-differentiated HL-60 cells provide a suitable
model system to study H1 receptors in human myeloid cells.
We show here that histamine, via H1 receptors, increases
[Ca2]1 in Bt2cAMP-differentiated HL-60 cells and that hista-
mine is an incomplete secretagogue.
Experimental Procedures
Materials. Pertussis toxin was donated by Dr. M. Yajima (Kaken
Pharmaceutical, Otsu, Japan). SK&F 96365 was a gift of Dr. D. Arndts
(Boehringer Ingelheim, Ingelheim, Germany). Clemastine, chlorphen-
iramine, diphenhydramine, and famotidine were purchased from Sigma
Chemie (Taufkirchen, Germany). myo-[2-3H]Inositol (10-20 Ci/mmol)
was purchased from Amersham-Buchler (Braunschweig, Germany).
Monoclonal antiphosphotyrosine antibody PY-20 (IgG2B) was from
ICN (Meckenheim, Germany). Sources of other materials have been
described elsewhere (12, 13, 24, 29-31, 35).
Cell culture. HL-60 cells were grown in suspension culture in RPMI
1640 medium supplemented with 10% (v/v) horse serum, 1% (v/v)
nonessential amino acids, 2 mM L-glutamine, 50 units/ml penicillin,
and 50 g/ml streptomycin, in a humidified atmosphere with 7% CO2
at 37’. To induce differentiation, HL-60 cells were seeded at 1 x 106
cells/ml and were cultured for 48 hr with 0.2 mM Bt2cAMP (12, 13).
Pertussis toxin treatment of HL-60 cells. Differentiation of
HL-60 cells was induced as described above. Twenty-four hours before
experiments, pertussis toxin (1 zg/ml) or its vehicle (control) was
added to the cell cultures. Under these conditions, pertussis toxin
functionally inactivated >98% ofthe cellular content ofpertussis toxin-
sensitive G proteins (15, 23).
Isolation of human neutrophils. Neutrophils were isolated from
buffy coats from the local blood bank or from fresh blood of individual
healthy volunteers (24, 29, 30). Cell preparations consisted of >95%
viable neutrophils, as revealed by trypan blue dye exclusion and Pap-
penheim-stained smears.
Measurement of [Ca211. [Ca2]1 was determined with the dye fura-
2/AM, as described (13), with modifications. HL-60 cells or neutrophils
were suspended at 1 x iO cells/ml in a buffer consisting of (in mM)
138 NaCl, 6 KC1, 1 MgSO4, 1 Na2HPO4, 5 NaHCO3, 5.5 glucose, and
20 HEPES-NaOH, pH 7.4, supplemented with 0.1% (w/v) bovine serum
albumin. Fura-2/AM was added at a concentration of 4 sM, and cells
were incubated for 10 mm at 37’. Thereafter, cells were diluted with
the aforementioned buffer to a concentration of 5 x 106 cells/ml and
were incubated for 45 mm at 37. Subsequently, cells were diluted with
the aforementioned buffer to a final concentration of 0.5 x 106 cells/
ml and were centrifuged at 250 X g for 10 mm at 20’. Cells were
suspended at 1.0 x 106 cells/ml in the aforementioned buffer and were
kept at 20 until measurement of [Ca2]. HL-60 cells were used for up
to 4 hr after loading with fura-2/AM (14). HL-60 cells or neutrophils
(1.0 x 106 cells) were suspended in 2 ml of the aforementioned buffer,
using acryl fluorescence cuvettes (Sarstedt, NUmbrecht, Germany).
Fluorescence was determined at 37’ , with constant stirring of the cells
at 1 X iO rpm, using a Ratio II spectrofluorometer (Aminco, Silver
Spring, MD). Cells were incubated for 3 mm at 37’, in the absence or
presence of various substances (e.g., histamine receptor antagonists),
before the addition of stimuli; basal fluorescence (basal [Ca2]1) was
measured for 1 mm. The excitation and emission wavelengths were 340
and 500 nm, respectively. Basal [Ca2J values and peak [Ca2]1 values
stimulated by agonists were calculated according to eq. 6 given in Ref.
36. Basal [Ca211 values were subtracted from the corresponding peak
[Ca2]1 values, to calculate the increase in [Ca2]1 induced by a given
stimulus. Influx of Mn2 into HL-60 cells was measured by quenching
of fura-2 fluorescence, as described (21). Unless stated otherwise, all
experiments were performed in the presence of extracellular Ca2 (1
mM CaCl2 added to the buffer 3 mm before stimuli). Basal [Ca)F]j in
freshly loaded HL-60 cells was 117 ± 18 nM (mean ± standard devia-
tion; 25 different preparations of cells). Basal [Ca2]1 in control cells
and in pertussis toxin-treated HL-60 cells did not differ significantly
(data not shown). Basal [Ca2]1 in human neutrophils was 102 ± 21 nM
(mean ± standard deviation; seven different preparations of cells).
Within 4 hr after loading of the HL-60 cells, basal [Ca2] did not rise
by more than 20 ni, and the responsiveness to any of the stimuli
studied did not change significantly during that time. In addition, there
was little variation in the responsiveness to the various stimuli using
different batches of HL-60 cells. Quantitative comparison of peak
[Ca2]1 values in HL-60 cells (e.g., comparison of control cells versus
antagonist- or pertussis toxin-treated cells) is based on the responses
to stimuli in different aliquots of a given preparation of loaded HL-60
cells. For the generation of complex concentration-response curves (see
Figs. 1-4), the following procedure was adopted. Immediately after an
aliquot of HL-60 cells was challenged with a stimulus, the next aliquot
of HL-60 cells was equilibrated to 37’ in a water bath. After 2 mm
([Ca2}1 values in the challenged aliquot of cells had already declined),
the fresh aliquot was placed into the fluorometer, to assess basal
[Ca2]1. By this procedure, up to 80 aliquots of cells could be analyzed
within 4 h. Due to the stability in the responsiveness of cells, agonist
and/or antagonist concentrations were not randomized, but they were
varied in a systematic manner by starting with agonists and/or antag-
onists at low concentrations.
Labeling of phosphoinositides in HL-60 cells and measure-
ment of inositol phosphate formation. For labeling of phosphoi-
nositides in HL-60 cells, cells were seeded at a density of 1 x 106 cells/
ml in inositol-free RPMI 1640 medium supplemented with 10% (v/v)
horse serum, 1% (v/v) nonessential amino acids, 2 mM L-glutamine, 50
units/ml penicillin, 50 ,g/ml streptomycin, 0.2 mM Bt2cAMP, and 2-5
sCi/ml myo-[2-3H]inositol, in a humidified atmosphere with 7% CO2
at 37’ . Cells were cultured for 48 hr. Prelabeled cells were centrifuged
at 250 x g for 10 mm at 20’. Cells were suspended in the buffer used
for the determination of [Ca2}1. Cells were recentrifuged and were
suspended in buffer. After another centrifugation ofthe cells, they were
suspended at 1 x i0 cells/mi in buffer. Reactions were performed at
37 in the aforementioned buffer supplemented with 1 mM CaCl2, in a
final volume of 200 zl. Reactions were initiated by addition of 100 sl
of cells to 100 zl of buffer containing solvent (control) or stimulus at
the desired concentration. Assays did not contain LiC1. Reactions were
stopped after 30 sec by addition of 400  of a solution consisting of
CHC13, CH3OH, and concentrated HC1 (100:200:1, v/v/v). Thereafter,
125 i of CHC13 and 25 sl of H20 were added to the reaction mixtures.
After centrifugation for phase separation, 350 l of the aqueous phase
were loaded on Dowex 1 x 8 columns (0.8 x 2 cm). Inositol phosphates
were eluted as described (37). The eluates (8 ml) were mixed with 12
ml of Fiow-szint IV scintillation fluid (Camberra Packard, Frankfurt/
Main, Germany), and radioactivity was determined by scintillation
counting.
Assay for 02 formation. 02 formation was monitored by contin-
uous measurement of ferricytochrome c reduction that was inhibitabie
by superoxide dismutase, using an Uvikon 810 dual-beam spectropho-
tometer (Kontron, Eching, Germany) (12, 13). Reaction mixtures (0.5
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ml) contained 2.5 x 106 HL-60 cells, 100 iM ferricytochrome c, and a
buffer consisting of (in mM) 138 NaCI, 6 KC1, 1 MgCl2, 1 CaCl2, 5.5
glucose, and 20 HEPES-NaOH, pH 7.4. Reaction mixtures were incu-
bated for 3 mm at 3T before the addition of stimuli. The absolute
amounts of 02 generated were calculated.
$-Glucuronidase release. Enzyme release was assessed as de-
scribed (13). Briefly, HL-60 cells (5.0 x 106 cells in 0.5 ml) were
suspended in the buffer used for the determination of 02 formation.
Cells were incubated for 5 mm at 3T in the presence of cytochalasin
B (5 g/ml) before the addition of stimuli. Reactions were conducted
for 10 mm and were terminated by placement of the tubes on ice.
Reaction mixtures were centrifuged at 1000 x g for 10 mm at 4. The
determinations of the activities of lactate dehydrogenase and fl-giucu-
ronidase in supernatant fluids of reaction mixtures and in cell lysates
were performed as described (24). Lactate dehydrogenase release from
cells generally amounted to <5% of cellular content (data not shown).
Tyrosine phosphorylation. Tyrosine phosphorylation of proteins
was performed as described (35). In brief, HL-60 cells (1.0 x 106 cells
in 40 l) were suspended in the buffer used for the determination of
02 formation. Cells were incubated for 3 mm at 3T before the addition
of stimuli (20 sl). Reactions were terminated after 1 mm by addition
of 30 zl of lysis buffer [6% (w/v) sodium dodecyl sulfate, 18% (v/v) 2-
mercaptoethanol, 30% (v/v) glycerol, 1 mM Na3VO4, and a trace amount
of Bromophenol blue dye, in 0.2 M Tris.HC1, pH 7.5]. Samples were
immediately incubated for 5 mm at 95’ . Thereafter, samples were
subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis
on gels containing 9% (w/v) acrylamide. The separated proteins were
then transferred onto nitrocellulose filters, which were saturated with
ovalbumin. Filters were incubated for 1 hr with 1 g/ml monoclonal
antiphosphotyrosine antibodies. Subsequently, filters were incubated
with a goat anti-mouse IgG-peroxidase conjugate. Bound antibodies
were detected by the enhanced chemiluminescence Western blotting
detection system (Amersham, Braunschweig, Germany). Phosphoty-
rosine-containing proteins were detected by exposure to medical X-ray
films (autoluminography).
Calculations. EC and IC50 values were obtained by graphically
analyzing the concentration-response curves shown in Figs. 1-4. The
pA2 for diphenhydramine versus histamine (see Fig. 2B) was calculated
as described (38, 39).
Results
Pertussis toxin partially inhibits histamine-induced
rises in [Ca211 in HL-60 cells. Concentnation-response
curves for the effects of fMet-Leu-Phe and histamine on
[Ca2]1 in Bt2cAMP-differentiated HL-6O cells are shown in
Fig. 1. fMet-Leu-Phe increased [Ca2]1 with an EC50 of 3 nM
and a maximum at 100 nM. Pertussis toxin decreased the
effectiveness of fMet-Leu-Phe (1 j.zM) by about 70% and ne-
duced its potency by almost 10-fold. Histamine increased [Ca2]
i in a concentration-dependent manner as well; the EC50 was 5
tM and a plateau was reached at 30-100 tM. The effectiveness
of histamine (100 zM) to increase [Ca2]1 was 30% of that of
fMet-Leu-Phe (1 sM). Pertussis toxin inhibited the effect of
histamine (100 zM) on [Ca2]1 by 35%.
H1 antagonists inhibit histamine-induced rises in
[Ca211 in HL-60 cells. Fig. 2A shows the effects of various
H1 antagonists on the concentration-response curve for hista-
mine. Clemastine (a potent H1 antagonist) (1, 2) at 100 nM
abolished the stimulatory effects of histamine on [Ca24]1. Chlor-
pheninamine, another potent H1 antagonist (1, 2), at 100 nM
reduced the effectiveness of histamine to increase [Ca2]1 by
>70% and increased its EC50 by about 2-fold. Impromidine (a
potent H2 agonist and H3 antagonist and weak H1 antagonist)
(1, 2) at 100 tM increased the EC50 for histamine by almost 10-
Fig. 1. Concentration-response curves for fMet-Leu-Phe- and histamine-
induced rises in [Ca2] in Bt2cAMP-differentiated HL-60 cells and effect
of pertussis toxin. Bt2cAMP-differentiated HL-60 cells were treated with
pertussis toxin (1 zg/ml) or its vehicle (control) for 24 hr. Thereafter, cells
were harvested and loaded with fura-2/AM, and the increases in [Ca2]
induced by various substances were assessed. #{149},Control cells; #{149},
pertussis toxin-treated cells. 0, fMet-Leu-Phe and histamine at the
designated concentrations did not increase [Ca2]. Data shown are the
means ± standard deviations of six experiments performed with different
preparations of HL-60 cells.
Fig. 2. Inhibition by chlorpheniramine, clemastine, diphenhydramine, and
impromidine of histamine-induced rises in [Ca2] in Bt2cAMP-differen-
tiated HL-60 cells. HL-60 cells were harvested and loaded with fura-2/
AM, and the increases in [Ca2jE induced by histamine at various concen-
trations, in the absence or presence of antagonists at fixed concentra-
tions, were assessed. Antagonist or solvent (control) was added to cells
3 mm before histamine. A, S, Control; #{149}, impromidine (100 MM); A,
chlorpheniramine (100 nM); #{149}, clemastine (100 nM). B, #{149}, Control; V,
diphenhydramine (30 nM); A, diphenhydramine (100 nM); I, diphenhydra-
mine (300 nM); #{149},diphenhydramine (1 zM); , diphenhydramine (3 MM).
0, Histamine at the designated concentrations did not increase [Ca2],.
Data shown are the means ± standard deviations of four experiments
performed with different preparations of HL-60 cells.
fold and reduced its effectiveness by about 20%. Diphenhydra-
mine (1, 2, 40), another H1 antagonist, at increasing fixed
concentrations shifted the concentration-nesponse curve for
histamine to the right and substantially reduced the effective-
ness of the agonist (Fig. 2B). The pA2 for diphenhydramine
was 7.9. Clemastine, chlorpheniramine, and diphenhydramine
inhibited rises in [Ca2]1 induced by histamine (100 MM) with
IC50 values of 3, 20, and 100 nM, respectively (Fig. 3). Improm-
idine was much less effective than the former substances, and
famotidine (a potent H2 antagonist) (41) was ineffective. Di-
phenhydramine, chlorpheniramine, clemastine, famotidine,
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MM) (see Figs. 2 and 4). Clemastine (100 nM) abolished the
effects of betahistine (see Fig. 4), whereas famotidine at up to
100 .tM was ineffective (data not shown). In contrast to betah-
istine, dimaprit and arpromidine (H2 agonists) (1, 2, 42) and
(R)-ce-methylhistamine (an H3 agonist) (1, 2), at up to 100 M,
did not induce rises in [Ca2]1 (data not shown).
Histamine activates nonselective cation channels in
HL-60 cells. In the presence of extracellular Ca2, fMet-Leu-
Phe caused a rapid and large increase in [Ca2}1, which returned
to basal values within 15-20 mm (Fig. 5); data shown only for
up to 5 mm). In comparison with fMet-Leu-Phe, histamine
induced a considerably lower and more transient increase in
[Ca2], which was terminated within 3-5 mm. In the absence
of extracellular Ca2, the magnitude and duration of rises in
[Ca2] induced by both substances were greatly reduced, sug-
gesting that fMet-Leu-Phe and histamine increased [Ca2]1
predominantly through influx of Ca2 from the extracellular
space. The imidazole derivative SK&F 96365 is a blocker of
nonselective cation channels and inhibits fMet-Leu-Phe-stim-
ulated influxes of Ca2 and Mn2 in human neutrophils (22).
In Bt2cAMP-differentiated HL-60 cells, SK&F 96365 (10 zM)
substantially reduced fMet-Leu-Phe- and histamine-induced
Ca2 influx (see Fig. 5). In contrast, SK&F 96365 did not inhibit
mobilization of Ca2 from intracellular stones.
Histamine-stimulated Mn2 influx in HL-60 cells was meas-
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Fig. 3. Concentration-response curves for the inhibitory effects of cle-
mastine, chlorpheniramine, diphenhydramine, impromidine, and famoti-
dine on histamine-induced rises in [Ca2] in Bt2cAMP-differentiated HL-
60 cells. HL-60 cells were harvested and loaded with fura-2/AM, and the
increases in [Ca2] induced by histamine at a fixed concentration (100
MM) in the presence of antagonists at various concentrations were
assessed. In the absence of antagonists, histamine (1 00 MM) increased
[Ca2] by 340 ± 28 nM (mean ± standard deviation of four experiments
performed with different preparations of HL-60 cells). Antagonists were
added to cells 3 mm before histamine. #{149}, Clemastine; U, chlorphenira-
mine; A, diphenhydramine; V, impromidine; #{149},famotidine. 0, Antagonists
at the indicated concentrations did not show an inhibitory effect on
histamine-induced rises in [Ca2],. Data shown are the means of four
experiments performed with different preparations of HL-60 cells. The
standard deviation values of the data generally amounted to <1 0% of
the means.
Fig. 4. Concentration-response curve for betahistine-induced rises in
[Ca21 in BtcAMP-differentiated HL-60 cells and inhibition of the effect
of betahistine by clemastine. Bt2cAMP-differentiated HL-60 cells were
harvested and loaded with fura-2/AM, and the increases in [Ca2],
induced by betahistine at various concentrations, in the absence or
presence of clemastine, were assessed. Clemastine or solvent (control)
was added to cells 3 mm before betahistine. S, Control; U, clemastine
(1 00 nM). Data shown are the means ± standard deviations of three
experiments performed with different preparations of HL-60 cells.
and impromidine, at up to 100 MM, did not affect rises in
[Ca2]1 induced by fMet-Leu-Phe (10 nM) (data not shown).
Betahistine is a partial agonist to induce rises in
[Ca211 in HL-6O cells. Betahistine (a weak partial H1 agonist)
(1, 2) increased [Ca2J1 with an EC50 of 30 MM and a maximum
at 100 ffM (Fig. 4). The effectiveness of betahistine to induce
rises in [Ca2]1 amounted to <15% of that of histamine (100
ured by quenching of fura-2 fluorescence. At an excitation
wavelength of 340 nm, fluorescence is increased by Ca2 and is
reduced by Mn2; at an excitation wavelength of 360 nm,
fluorescence is quenched by Mn2 but is insensitive to changes
in [Ca2] (21). At both excitation wavelengths, Mn2 induced
a slow decrease in fluorescence, indicating basal Mn2 influx
(Fig. 6). At an excitation wavelength of 340 nm but not 360
nm, histamine (100 tM) transiently increased fluorescence,
:
conlrol SK&F 96365
Fig. 5. Effects of extracellular Ca2 and of SK&F 96365 on fMet-Leu-
Phe- and histamine-induced rises in [Ca2] in Bt2cAMP-differentiated HL-
60 cells. HL-60 cells were harvested and loaded with fura-2/AM, and the
increases in [Ca2] induced by fMet-Leu-Phe (1 00 nM) (A and B) and
histamine (1 00 MM) (C and D) were assessed. Arrows, addition of stimuli.
Three minutes before stimuli, solvent (control) (A and C) or SK&F 96365
(10 MM)(B and D) was added to cells. Trace 1 , presence of CaCI2 (1 mM);
trace 2, presence of EGTA (1 mM) without added CaCI2. Superimposed
original fluorescence tracings are shown. Similar results were obtained
in three experiments performed with different preparations of HL-60
cells.
A1 mm41
t f
Mn’ histamine
4,
4,
2)
4,
0
4,
is
Si
B
p   1

I
Mn’4 histamine
1000
300
0
C)
E300
100
control PDD
H1 Receptors in Differentiated HL-60 Cells 231
Fig. 6. Effects of histamine on Mn2 influx in BtcAMP-differentiated HL-
60 cells. Cells were harvested and loaded with fura-2/AM, and fura-2
fluorescence was monitored at an excitation wavelength of 340 nm
(trace 1 ) or 360 nm (trace 2). The emission wavelength was 500 nm.
Experiments were performed in the absence of added CaCI2. Arrows,
addition of MnCI2 and histamine (1 00 MM each). A, Experiments per-
formed in the absence of SK&F 96365 (control); B, experiments per-
formed in the presence of SK&F 96365 (1 0 MM). SK&F 96365 or solvent
(control) was added to cells 3 mm before MnCl2. Superimposed original
fluorescence tracings are shown. Similar results were obtained in three
experiments performed with different preparations of HL-60 cells.
TABLE 1
Effects of fMet-Leu-Phe and histamine on phosphoinositide
degradation in Bt2cAMP-differentiated HL-60 cells
HL-60 cells were cultured for 48 hr in inositol-free RPMI medium supplemented
with myo-[2-3H]inositol and BtcAMP, under the conditions described in Experi-
mental Procedures. Thereafter, labeled cells were washed. HL-60 cells (1 x 106
cells in a volume of 200 Ml) were exposed to solvent (control), fMet-Leu-Phe (1 MM),
or histamine (100 MM) for 30 sec at 37#{176}.in the buffer used for the determination of
[Ca2] supplemented with 1 mM CaCI2. Stopping of the reactions, extraction of
inositol phosphates, and separation of inositol phosphates on Dowex 1 x 8 columns
were performed as described in Experimental Procedures. Data shown are the
means ± standard deviations of assay triplicates. Similar results were obtained in
1 0 experiments performed with different preparations of HL-60 cells.
lnosit phosphates’
Stmulus
lnsP lnsP2 lnsP3
dpm
Solvent (control) 789 ± 47 705 ± 46 159 ± 40
fMet-Leu-Phe 91 8 ± 1 65 1 442 ± 40 407 ± 193
Histamine 925 ± 1 38 838 ± 169 192 ± 45
a lnsP, inositol monophosphate; lnsP2, inositol bisphosphate.
reflecting release of Ca2 from intracellular stores. At excitation
wavelengths of 340 and 360 nm, histamine substantially in-
creased the rate of basal fluorescence quenching, reflecting
Mn2 influx. SK&F 96365 blocked histamine-induced Mn2
influx but not Ca2 mobilization from intracellular stores. Qual-
itatively the same results were obtained with fMet-Leu-Phe as
stimulus (data not shown). Thus, histamine activates nonselec-
tive cation channels, as does fMet-Leu-Phe (see Figs. 5 and 6)
(21, 22).
Histamine activates phospholipase C in HL-60 cells.
Because small parts of fMet-Leu-Phe- and histamine-induced
rises in [Ca2]1 were due to mobilization of Ca2 from intracel-
lular stores (see Fig. 5), the effects of these substances on
phosphoinositide degradation were studied. fMet-Leu-Phe sub-
stantially stimulated inositol phosphate formation, in particu-
lar the formation of inositol bisphosphate and InsP3 (Table 1).
In comparison with fMet-Leu-Phe, histamine only slightly
stimulated formation of inositol phosphates.
PMA differentially inhibits fMet-Leu-Phe- and hista-
mine-induced rises in [Ca211 in HL-60 cells. Brief expo-
sure of neutrophilic cells to PMA, an activator of protein kinase
C, inhibits fMet-Leu-Phe-induced phosphoinositide degnada-
tion and rises in [Ca2J1, through uncoupling of receptors from
G proteins and uncoupling of G proteins from effectors (9, 10,
14, 43). Treatment of HL-60 cells with PMA resulted in sub-
stantially diminished stimulatony effects of fMet-Leu-Phe on
[Ca2]1 (Fig. 7). Partial resistance to inhibition by PMA of
fMet-Leu-Phe-induced rises in [Ca2] in Bt2cAMP-diffenen-
tiated HL-60 cells was also reported in another study (14). In
contrast, PMA abolished the stimulatory effects of histamine
on [Ca2]1 (see Fig. 7). PDD, which does not activate protein
kinase C, did not affect fMet-Leu-Phe- or histamine-induced
rises in [Ca2]. These data indicate that the inhibitory effects
of PMA on rises in [Ca2]1 were mediated via protein kinase C.
Histamine does not stimulate 02 formation, -glucu-
ronidase release, and tyrosine phosphorylation in HL-
60 cells. In order to answer the question of whether histamine-
induced rises in [Ca2]1 are linked to activation of specific cell
functions, the effects of histamine on 02 formation and f-
glucuronidase release were studied. fMet-Leu-Phe effectively
activated 02 formation and fl-glucuronidase release in HL-60
cells (Table 2). In contrast, histamine was devoid of any stim-
ulatory effects. The lack of effect of histamine was also appar-
ent in the presence of famotidine, i.e., when possible inhibitory
effects of histamine, via H2 receptors, on 02 formation and f3-
glucuronidase release were blocked (see Table 2) (27, 29, 30).
fMet-Leu-Phe-induced 02 formation is potentiated by ATP
and UTP (12, 13, 24). However, histamine and betahistine (0.1
and 1 mM each) did not potentiate 02 formation induced by
fMet-Leu-Phe (30 nM and 1 sM) in Bt2cAMP-differentiated
HL-60 cells, regardless of the presence or absence of famotidine
(10 MM) (data not shown). Similanily, histamine failed to poten-
tiate fMet-Leu-Phe-induced -glucuronidase release in
i- 100
0
 1000 T
I
PMA
Fig. 7. Effects of PMA and PDD on fMet-Leu-Phe- and histamine-induced
rises in [Ca2] in Bt2cAMP-differentiated HL-60 cells. HL-60 cells were
harvested and loaded with fura-2/AM, and the increases in [Ca2J
induced by fMet-Leu-Phe (1 00 nM) (A-C) and histamine (100 MM) (D-F)
were assessed. Arrows, addition of stimuli. Three minutes before stimuli,
solvent (control) (A and D), PMA (1 00 ng/ml) (B and E), or PDD (1 00 ng/
ml) (C and F) was added to cells. Superimposed original fluorescence
tracings are shown. Similar results were obtained in three experiments
performed with different preparations of HL-60 cells.
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TABLE 2
Effects of fMet-Leu-Phe and histamine on 02 formation and fi-
glucuronidase release in BtcAMP-differentiated HL-60 cells
02 formation and l-glucuronidase release in Bt2cAMP-differentiated HL-60 cells
were assessed in the presence of various stimuli. Famotidine was added to cells 3
mm before histamine when 02 formation was assessed and 5 mm before histamine
when l-glucuronidase release was studied. Cytochalasin B (5 g/ml) was added
to cells 5 mm before stimuli when 1-glucuronidase release was determined. For
further experimental details, see Experimental Procedures. Data shown are the
means ± standard deviations of assay triplicates. Similar results were obtained in
three experiments with difterent preparations of HL-60 cells.
Stimulus 02 formation -GIucurondase
nmol/106 cells % of cellular content
Solvent (control) 0 5.2 ± 0.5
fMet-Leu-Phe (1 MM) 6.5 ± 0.8 26.3 ± 1.3
Histamine (100 MM) 0 5.1 ± 0.2
Histamine (1 mM) 0 4.9 ± 0.4
Histamine (1 00 MM) + famotidine 0 5.3 ± 0.6
(10 MM)
94bps
67
43r
30P
DF
123456
Fig. 8. Effects of fMet-Leu-Phe and histamine on tyrosine phosphoryla-
tion in BtcAMP-differentiated HL-60 cells. Cells (1 .0 x 106/tube) were
incubated with various stimuli for 1 mm. Famotidine was added to cells
3 mm before histamine. Proteins were analyzed as described in Experi-
mental Procedures. The autoluminogram of a blot is shown. Lane 1,
solvent (control); lane 2, fMet-Leu-Phe (1 MM); lane 3, fMet-Leu-Phe (10
MM); lane 4, histamine (100 MM); lane 5, histamine (1 mM); lane 6, histamine
(1 00 MM) plus famotidine (1 0 MM). Numbers on the left, molecular masses
of marker proteins (kDa); OF, dye front. Similar results were obtained in
three experiments performed with different preparations of HL-60 cells.
Bt2cAMP-diffenentiated HL-60 cells under various expenimen-
tal conditions, whereas ATP and UTP synergize with fMet-
Leu-Phe (data not shown) (13, 24).
Tyrosine phosphorylation is an important signal for the
activation of 02 formation by fMet-Leu-Phe (10, 20). Thus,
the question arose of whether the lack of stimulation by hista-
mine of 02 formation was due to a lack of activation of tyrosine
phosphorylation. fMet-Leu-Phe stimulated tyrosine phosphor-
ylation of 100/110-kDa proteins in HL-60 cells (Fig. 8). In
contrast, histamine failed to stimulate tyrosine phosphoryla-
tion, in the absence or presence of famotidine.
Histamine and betahistine do not induce rises in
[Ca2]1 in neutrophils. Finally, the effects of fMet-Leu-Phe,
histamine, and betahistine on [Ca2] in human neutrophils
were studied. As was the case for Bt2cAMP-differentiated HL-
60 cells, fMet-Leu-Phe (1 MM) induced large increases in [Ca2]
i in human neutrophils (data not shown) (see Fig. 1). However,
histamine and betahistine (1 MM to 1 mM each) consistently
failed to reveal any stimulatory effect on [Ca2]1 in seven
preparations of human neutrophils (data not shown).
Discussion
Functional H1 receptors coupled to pertussis toxin-
sensitive G proteins are present in Bt2cAMP-differen-
tiated HL-60 cells. Our data suggest that, in Bt2cAMP-
differentiated HL-60 cells, H1 receptors mediate increases in
[Ca2]1. This assumption is supported by several findings. Most
importantly, histamine- and betahistine-induced rises in
[Ca2] were inhibited by H1 but not by H2 antagonists (see
Figs. 2-4). Additionally, the pA2 for diphenhydramine versus
histamine in Bt2cAMP-differentiated HL-60 cells is in agree-
ment with that obtained for other systems (see Fig. 2) (1, 40).
The potency order of clemastine > chlorpheninamine > diphen-
hydramine >> impromidine, to inhibit the effects of histamine
on [Ca2] in Bt2cAMP-differentiated HL-60 cells, is in accord-
ance with the classification of an H1 receptor as well (see Figs.
2 and 3) (1, 2, 40). Moreover, noncompetitive antagonism of
clemastine, chlorpheniramine, and diphenhydramine with his-
tamine at H1 receptors is documented in the literature (see Fig.
2) (1, 40). The lack of effect of H1 antagonists on fMet-Leu-
Phe-induced rises in [Ca2]1 argues against nonspecific effects
of these substances. Similarly to other systems, betahistine is
a weak partial H1 agonist in Bt2cAMP-differentiated HL-60
cells, and H2 and H3 agonists failed to induce rises in [Ca2]
(see Figs. 2 and 4) (1, 2).
As in other cell types (1-7), H1 receptors in Bt2cAMP-
differentiated HL-60 cells mediate activation of phospholipase
C and increases in [Ca2] (see Fig. 1 and Table 1). The finding
that histamine only marginally activated phosphoinositide deg-
radation fits well with the fact that, in the absence of extracel-
lular Ca2, histamine induced only small increases in [Ca2]
(see Fig. 5 and Table 1). This increase presumably reflects
InsP3-mediated mobilization of Ca2 from intracellular stores.
The greatest part of histamine-induced rises in [Ca2] in HL-
60 cells was attributable to activation of nonselective cation
channels (see Figs. 5 and 6). Activation of cation channels via
H1 receptors was also reported for other systems (2, 44).
H1 receptor-mediated increases in [Ca2] in HL-60 cells were
partially inhibited by pretreatment with pertussis toxin (see
Fig. 1). These data indicate that, in these cells, H1 receptors
interact with G proteins of the G1 family, as do formyl peptide
receptors (8-10). Interestingly, H1 receptor-mediated increases
in [Ca2] in HL-60 cells were more resistant to inhibition by
pertussis toxin than were those induced by fMet-Leu-Phe (see
Fig. 1). Thus, by analogy to ATP and UTP receptors, H1
receptors in HL-60 cells may interact with pertussis toxin-
sensitive and pertussis toxin-insensitive G proteins (12-15).
Histamine is an incomplete secretagogue. In HL-60
cells, fMet-Leu-Phe and histamine activate phospholipase C
and nonselective cation channels, resulting in increases in
[Ca2] (see Figs. 5 and 6 and Table 1). There are, however,
differences between fMet-Leu-Phe and histamine, i.e., fMet-
Leu-Phe is substantially more effective than histamine in ac-
tivating phospholipase C and inducing rises in [Ca2], (see Fig.
1 and Table 1). Unlike fMet-Leu-Phe, histamine did not stim-
ulate 02 formation, 3-glucunonidase release, and tyrosine phos-
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phorylation (see Fig. 8 and Table 2). These data suggest that
even maximal stimulation of H1 receptors did not result in the
generation of sufficiently high levels of intracellular signals to
induce activation of specific cell functions, i.e., 02 formation
and enzyme release. There are differences in the pertussis toxin
sensitivity of fMet-Leu-Phe- and histamine-induced rises in
[Ca2]1 (see Fig. 1). Moreover, fMet-Leu-Phe- and histamine-
induced rises in [Ca2]1 were differentially inhibited by PMA
(see Fig. 7). These data point to differences in the interactions
of H1 and formyl peptide receptors with G proteins and in the
subsequent interaction of G proteins with effectors. Taken
together, fMet-Leu-Phe and histamine are functionally none-
quivalent, and histamine is an incomplete secretagogue.
In addition to histamine, ATP, UTP, and leukotniene B4 are
incomplete secretagogues (12, 13, 23, 24, 45). Moreover, inter-
action of H1, ATP, and leukotniene B4 receptors with G proteins
differs from the interaction of fonmyl peptide receptors with G
proteins (see Figs. 1 and 7) (12-15, 17). However, leukotriene
B4, ATP, and UTP on one hand and histamine on the other
hand are functionally nonequivalent. This view is supported by
the findings that functional leukotniene B4 receptors and ATP
and UTP receptors are present not only in Bt2cAMP-differen-
tiated HL-60 cells but also in human neutrophils (9, 10, 12-15,
18, 24). By comparison, there is no evidence for the existence
of functional H1 receptors in neutrophils, as assessed by meas-
unement of [Ca2]1. Furthermore, leukotriene B4, ATP, and
UTP activate 02 formation to at least a small degree or
enhance the stimulatory effects of fMet-Leu-Phe on O2 for-
mation (12, 13, 23, 24). In contrast, histamine is devoid of any
stimulatory effect on 02 formation in neutrophils and in
Bt2cAMP-diffenentiated HL-60 cells (see Table 3) (27, 29).
What may be the regulatory importance of H1 recep-
tors in HL-60 cells?. In addition to Bt2cAMP-differentiated
HL-60 cells, functional H1 receptors are present in HL-60
pnomyelocytes, but there is no evidence to support the assump-
tion that H1 receptors play a role in the induction of differen-
tiation of HL-60 cells (31). However, the absence of functional
H1 receptors in human neutnophils may point to an as yet
unknown role of these receptors in the regulation of differen-
tiation and/or proliferation (31). Interestingly, expression of
H1 receptors in cultured smooth muscle cells is also diffenentia-
tion dependent (46). In addition, H1 receptors may be involved
in the regulation of proliferation of human fibroblasts, carci-
noma cells, and melanoma cells (47, 48).
The possibility cannot be excluded that H1 receptors in HL-
60 cells are of no regulatory importance at all. It should be kept
in mind that HL-60 cells are not normal myeloid cells but were
derived from a patient with acute promyelocytic leukemia (49).
Thus, the expression of functional H1 receptors in Bt2cAMP-
differentiated HL-60 cells could be a tumor cell-associated
abnormality in signal transduction, rather than a phenomenon
that occurs in normal neutrophils. Abnormalities in signal
transduction processes in Bt2cAMP-differentiated HL-60 cells,
in comparison with neutrophils, are not without precedence.
First, ATP and UTP per se activate 02 formation and f3-
glucuronidase release in Bt2cAMP-differentiated HL-60 cells
but not in human neutrophils (12, 13, 24). Second, fMet-Leu-
Phe induces j3-glucuronidase release in Bt2cAMP-differentiated
HL-60 cells in the absence of cytochalasin B but not in human
neutrophils (13, 23, 24). Third, PMA stimulates fl-glucuroni-
dase release in Bt2cAMP-differentiated HL-60 cells but not in
neutrophils (13, 50). Finally, Bt2cAMP-differentiated HL-60
cells fail to express a cytosolic component of NADPH oxidase
that is normally present in human neutrophils (51). Thus,
caution must be exerted when results obtained with Bt2cAMP-
differentiated HL-60 cells are extrapolated to human neutro-
phils.
In conclusion, histamine increases [Ca2], in Bt2cAMP-dif-
ferentiated HL-60 cells via H1 receptors coupled to pertussis
toxin-sensitive G proteins and, possibly, to pertussis toxin-
insensitive G proteins. Histamine is an incomplete secreta-
gogue, inasmuch as it does not stimulate 02 formation and /3-
glucuronidase release. Regardless of the regulatory importance
of H1 receptors in Bt2cAMP-differentiated HL-60 cells, this
system provides a suitable model to study the pharmacology of
H1 receptors.
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